XFXiaoning Feng

Xiaoning Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoning Feng has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Chai

    Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

    6 shared publications
  • Jing Hao

    Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, Shandong, PR China

    6 shared publications
  • Lanlan Liu

    Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Shandong, China

    6 shared publications
  • Ruihong Zhang

    Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Shandong, China

    6 shared publications
  • Sujuan Zhi

    Key Laboratory of the Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine Shandong University Jinan Shandong People's Republic of China

    6 shared publications
  • Weiwei Cui

    Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Shandong, China

    6 shared publications

Latest Publications

  • Open Access

    Supplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Supplementary Table S1: Primer sequence for qPCR Supplementary Table S2: LncRNAs regulated by Sohlh2 in colon cancer cells Supplementary Table S3: The correlation of Sohlh2 expression and clinical characteristics Supplementary Figure 1: The protein levels of Lgr5, CD133 were downregulated in Sohlh2-overexpressing CSC-derived xenografts, and the levels of TFF2 were upregulated. Supplementary Figure S2: Sohlh2 downregulated the expression of β-catenin in xenograft tumors. Supplementary Figure S3: Sohlh2 upregulated the expression of APC in HCT116 CSCs.

  • Open Access

    Data from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Colon cancer stem cells (CSC) are tumor-initiating cells that drive tumorigenesis and progression through self-renewal and various differentiation potency. Therefore, the identification of factors critical for colon CSC function is vital for the development of therapies. Sohlh2 belongs to the superfamily of bhlh transcription factors and serves as a tumor suppressor in several tumors. The role of Sohlh2 in CSCs remains unknown. Here we demonstrated that Sohlh2 was related to the inhibition of LncRNA-H19/miR-141/β-catenin signaling and led to the consequent suppression of colon CSC stemness and the promotion of colon CSC differentiation in vitro and in vivo. Moreover, Sohlh2 could directly bind to the promoter of LncRNA-H19 and repress its transcription activity. LncRNA-H19 mediated the effects of Sohlh2 on colon CSC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh2 and LncRNA-H19, β-catenin, Lgr5, CD133 expression levels, and positive correlation between Sohlh2 and MUC2, TFF2 expression in colon cancer tissues. Collectively, our findings suggest an important role of the Sohlh2/LncRNA-H19/miR-141/β-catenin pathway in regulating colon CSC stemness and differentiation, suggesting potential therapeutic targets for colon cancer.Implications:This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon CSCs.


  • Open Access

    Supplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Supplementary Table S1: Primer sequence for qPCR Supplementary Table S2: LncRNAs regulated by Sohlh2 in colon cancer cells Supplementary Table S3: The correlation of Sohlh2 expression and clinical characteristics Supplementary Figure 1: The protein levels of Lgr5, CD133 were downregulated in Sohlh2-overexpressing CSC-derived xenografts, and the levels of TFF2 were upregulated. Supplementary Figure S2: Sohlh2 downregulated the expression of β-catenin in xenograft tumors. Supplementary Figure S3: Sohlh2 upregulated the expression of APC in HCT116 CSCs.

  • Open Access

    Data from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Colon cancer stem cells (CSC) are tumor-initiating cells that drive tumorigenesis and progression through self-renewal and various differentiation potency. Therefore, the identification of factors critical for colon CSC function is vital for the development of therapies. Sohlh2 belongs to the superfamily of bhlh transcription factors and serves as a tumor suppressor in several tumors. The role of Sohlh2 in CSCs remains unknown. Here we demonstrated that Sohlh2 was related to the inhibition of LncRNA-H19/miR-141/β-catenin signaling and led to the consequent suppression of colon CSC stemness and the promotion of colon CSC differentiation in vitro and in vivo. Moreover, Sohlh2 could directly bind to the promoter of LncRNA-H19 and repress its transcription activity. LncRNA-H19 mediated the effects of Sohlh2 on colon CSC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh2 and LncRNA-H19, β-catenin, Lgr5, CD133 expression levels, and positive correlation between Sohlh2 and MUC2, TFF2 expression in colon cancer tissues. Collectively, our findings suggest an important role of the Sohlh2/LncRNA-H19/miR-141/β-catenin pathway in regulating colon CSC stemness and differentiation, suggesting potential therapeutic targets for colon cancer.Implications:This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon CSCs.

  • Open Access

    Supplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Supplementary Table S1: Primer sequence for qPCR Supplementary Table S2: LncRNAs regulated by Sohlh2 in colon cancer cells Supplementary Table S3: The correlation of Sohlh2 expression and clinical characteristics Supplementary Figure 1: The protein levels of Lgr5, CD133 were downregulated in Sohlh2-overexpressing CSC-derived xenografts, and the levels of TFF2 were upregulated. Supplementary Figure S2: Sohlh2 downregulated the expression of β-catenin in xenograft tumors. Supplementary Figure S3: Sohlh2 upregulated the expression of APC in HCT116 CSCs.

  • Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

    by Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, et al.

    Colon cancer stem cells (CSC) are tumor-initiating cells that drive tumorigenesis and progression through self-renewal and various differentiation potency. Therefore, the identification of factors critical for colon CSC function is vital for the development of therapies. Sohlh2 belongs to the superfamily of bhlh transcription factors and serves as a tumor suppressor in several tumors. The role of Sohlh2 in CSCs remains unknown. Here we demonstrated that Sohlh2 was related to the inhibition of LncRNA-H19/miR-141/β-catenin signaling and led to the consequent suppression of colon CSC stemness and the promotion of colon CSC differentiation in vitro and in vivo. Moreover, Sohlh2 could directly bind to the promoter of LncRNA-H19 and repress its transcription activity. LncRNA-H19 mediated the effects of Sohlh2 on colon CSC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh2 and LncRNA-H19, β-catenin, Lgr5, CD133 expression levels, and positive correlation between Sohlh2 and MUC2, TFF2 expression in colon cancer tissues. Collectively, our findings suggest an important role of the Sohlh2/LncRNA-H19/miR-141/β-catenin pathway in regulating colon CSC stemness and differentiation, suggesting potential therapeutic targets for colon cancer. Implications: This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon CSCs.